Scientists have studied the optical properties of nano-diamond particles that have explosive properties when interacting with various macromolecules. The results of these examinations were astonishing. The study will help create original biosensors with improved optical properties. These structures, called detonation nanodiamond (DND), can be used to detect cells with cancer potential due to their explosive properties. This makes the potential particles very special. How do DNDs work?
DND is a diamond-like carbon nanostructure with a structural crystal lattice. In recent years, scientists have been working on the interaction of DND with biological structures and biomacromolecules. According to the findings, DNDs can be used to treat tumor cells as well as to develop biosensors and biocompatible implants. DNDs can significantly alter the properties of these molecules when interacting with biomacromolecules. This is very important in biomedical research, as the relationship between the structure of the substance and the irradiation properties is important when creating physiologically active new substances. Today, the scope of biosensors is expanding rapidly. Nanocarriers are currently being actively used in biomedical research. Being semiconductor and piezoelectric; it helps to use these cells in areas such as electronic devices and biosensors. Scientists from the National University of Nuclear Research conducted an experiment investigating the interaction of these cells with molecules such as porphyrin, myoglobin, tryptophan, and DNA, which are of great importance in the field of drug production. DNDs of 5 nanometer size were sprayed to the molecules mentioned in the experiment to form a thin layer.
Ekaterina Boruleva of the National University of Nuclear Research: “The results of these studies have shown that nano-diamonds increase the intensity of irradiation. He explained. According to scientists, this shows that non-irradiating DNDs increase the signal of biomacromolecule components. In the near future, scientists are planning to produce a prototype biosensor based on albumin nanoparticles to deliver drugs in the body. They also aim to develop new application technologies with and by producing a prototype biosensor based on DNDs to record early cancer and precancerous conditions.
